Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMR71ST)

Drug Name	ASP1929 DMR71ST
Synonyms	Cetuximab sarotalocan
Drug Type	Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

1 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Head and neck cancer	DISBPSQZ	2D42	Phase 3	[1]
------------------------------------------------------------------------------------

1 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Solid tumour/cancer	DISZR48F	2A00-2F9Z	Phase 1/2	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT03769506) ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy. U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT04305795) An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors. U.S. National Institutes of Health.